drugset / Trial / NCT03472053
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This Phase 2 is a randomized study in advanced Non-Small Cell lung cancer patients to evaluate safety and efficacy of aerosolized BIO-11006 in conjunction with chemotherapy.
Timeline
- Start
- 2018-02-01
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIO-11006 | Peptide | 125 mg | — |
| Background | Carboplatin | Small molecule | 6 unknown | — |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | — |